You Position: Home > Journal issue
Acta Pharmaceutica Sinica
2023:
2022:
2021:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2020:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2019:
- Issue 1 |
- Issue 2 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2018:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2017:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2016:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2015:
2008:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2007:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2006:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2005:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2004:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2003:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2002:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2001:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
2000:
- Issue 1 |
- Issue 2 |
- Issue 3 |
- Issue 4 |
- Issue 5 |
- Issue 6 |
- Issue 7 |
- Issue 8 |
- Issue 9 |
- Issue 10 |
- Issue 11 |
- Issue 12 |
1999:
1998:
Acta Pharmaceutica Sinica
1
Activatable cell-penetrating peptides: a potential activatable modality for diseases diagnosis and therapy
Acta Pharmaceutica Sinica, Volume 51, Issue 4,2016, Pages 529-535, doi:10.16438/j.0513-4870.2015-0656
2
Antitumer effect of supernatant from co-culture of human embryonic stem cells and breast cancer cells on MDA-MB-231 cells in vitro
Acta Pharmaceutica Sinica, Volume 51, Issue 4,2016, Pages 552-557, doi:10.16438/j.0513-4870.2015-0760
3
Simultaneous quantification of 7 coumarins in common cnidium fruit by GC-MS
Acta Pharmaceutica Sinica, Volume 51, Issue 4,2016, Pages 626-630, doi:10.16438/j.0513-4870.2015-0649
4
@@
Acta Pharmaceutica Sinica, Volume 51, Issue 4,2016, Pages 672-676, doi:10.16438/j.0513-4870.2014-0856
5
Synthesis and biological evaluation of novel chalcone aromatic oxygen alkyl acids compounds
Acta Pharmaceutica Sinica, Volume 51, Issue 4,2016, Pages 600-605, doi:10.16438/j.0513-4870.2015-0958